Areteia Therapeutics
$1.80B
Oral drug targeting eosinophils for severe eosinophilic asthma
- $1.80B last priced transaction (>1yr old) (as of 2024-02)
- 4 sourced signals across 2 data sources
Loading the full interactive profile on VizierAtlas…
Oral drug targeting eosinophils for severe eosinophilic asthma
Loading the full interactive profile on VizierAtlas…